BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 36568753)

  • 21. The acceptability of self-sampled screening for HPV DNA: a systematic review and meta-analysis.
    Nelson EJ; Maynard BR; Loux T; Fatla J; Gordon R; Arnold LD
    Sex Transm Infect; 2017 Feb; 93(1):56-61. PubMed ID: 28100761
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Self-sampling as the principal modality for population based cervical screening: Five-year follow-up of the PaVDaG study.
    Stanczuk GA; Currie H; Forson W; Baxter G; Lawrence J; Wilson A; Palmer T; Arbyn M; Cuschieri K
    Int J Cancer; 2022 Apr; 150(8):1350-1356. PubMed ID: 34850395
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Leveraging COVID-era innovation for cervical cancer screening: Clinician awareness and attitudes toward self-sampling and rapid testing for HPV detection.
    Rodriguez NM; Brennan LP; Claure L; Balian LN; Champion VL; Forman MR
    PLoS One; 2023; 18(3):e0282853. PubMed ID: 36893182
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Acceptability and Preference of Vaginal Self-sampling for Human Papillomavirus (HPV) Testing among a Multi-ethnic Asian Female Population.
    Khoo SP; Lim WT; Rajasuriar R; Nasir NH; Gravitt P; Woo YL
    Cancer Prev Res (Phila); 2021 Jan; 14(1):105-112. PubMed ID: 32917643
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Urine collection in cervical cancer screening - analytical comparison of two HPV DNA assays.
    Tranberg M; Jensen JS; Bech BH; Andersen B
    BMC Infect Dis; 2020 Dec; 20(1):926. PubMed ID: 33276740
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preventing cervical cancer using HPV self-sampling: direct mailing of test-kits increases screening participation more than timely opt-in procedures - a randomized controlled trial.
    Tranberg M; Bech BH; Blaakær J; Jensen JS; Svanholm H; Andersen B
    BMC Cancer; 2018 Mar; 18(1):273. PubMed ID: 29523108
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acceptability of vaginal self-sampling with high-risk human papillomavirus testing for cervical cancer screening: a French questionnaire-based study.
    Bertucci M; Bonnet E; Satger L; Kreiche A; Chappert JL; Loy-Morel S; Segondy M; Daurès JP; Boulle N
    Women Health; 2021 Jan; 61(1):83-94. PubMed ID: 33106125
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human papillomavirus self-sampling for long-term non-attenders in cervical cancer screening: A randomised feasibility study in Estonia.
    Veerus P; Hallik R; Jänes J; Jõers K; Paapsi K; Laidra K; Innos K
    J Med Screen; 2022 Mar; 29(1):53-60. PubMed ID: 34694179
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Performance of Xpert HPV on Self-collected Vaginal Samples for Cervical Cancer Screening Among Women in South Africa.
    Saidu R; Kuhn L; Tergas A; Boa R; Moodley J; Svanholm-Barrie C; Persing D; Campbell S; Tsai WY; Wright TC; Denny L
    J Low Genit Tract Dis; 2021 Jan; 25(1):15-21. PubMed ID: 33105451
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A randomized, controlled trial of two strategies of offering the home-based HPV self-sampling test to non- participants in the Flemish cervical cancer screening program.
    Kellen E; Benoy I; Vanden Broeck D; Martens P; Bogers JP; Haelens A; Van Limbergen E
    Int J Cancer; 2018 Aug; 143(4):861-868. PubMed ID: 29569715
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acceptability and Feasibility of HPV Self-Sampling as an Alternative Primary Cervical Cancer Screening in Under-Screened Population Groups: A Cross-Sectional Study.
    Wong EL; Cheung AW; Wong AY; Chan PK
    Int J Environ Res Public Health; 2020 Aug; 17(17):. PubMed ID: 32867315
    [No Abstract]   [Full Text] [Related]  

  • 32. Accuracy of HPV testing on self-collected and clinician-collected samples for different screening strategies in African settings: A systematic review and meta-analysis.
    Sy F; Greuel M; Winkler V; Bussmann H; Bärnighausen T; Deckert A
    Gynecol Oncol; 2022 Aug; 166(2):358-368. PubMed ID: 35781165
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long term results of follow-up after HPV self-sampling with devices Qvintip and HerSwab in women non-attending cervical screening programme.
    Bokan T; Ivanus U; Jerman T; Takac I; Arko D
    Radiol Oncol; 2021 Jan; 55(2):187-195. PubMed ID: 33764704
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effectiveness and feasibility of self-sampling for human papillomavirus testing for internet-based cervical cancer screening.
    Li J; Wu R; Qu X; Huang X; Li L; Lin Z; Zhang Z; Deng J; Liu R; Zhao X; Zhang S; Lin B; An R; Zhao C; Li M; Zhao Y; Wei L
    Front Public Health; 2022; 10():938272. PubMed ID: 36420004
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Strategies to Increase Cervical Cancer Screening With Mailed Human Papillomavirus Self-Sampling Kits: A Randomized Clinical Trial.
    Winer RL; Lin J; Anderson ML; Tiro JA; Green BB; Gao H; Meenan RT; Hansen K; Sparks A; Buist DSM
    JAMA; 2023 Nov; 330(20):1971-1981. PubMed ID: 38015219
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Emerging role of HPV self-sampling in cervical cancer screening for hard-to-reach women: Focused literature review.
    Madzima TR; Vahabi M; Lofters A
    Can Fam Physician; 2017 Aug; 63(8):597-601. PubMed ID: 28807952
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Screening for High-Risk Human Papillomavirus Using Passive, Self-Collected Menstrual Blood.
    Naseri S; Young S; Cruz G; Blumenthal PD
    Obstet Gynecol; 2022 Sep; 140(3):470-476. PubMed ID: 35926207
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Utilization of self-sampling kits for HPV testing in cervical cancer screening - pilot study].
    Ondryášová H; Koudeláková V; Drábek J; Vaněk P; Slavkovský R; Hajdúch M
    Ceska Gynekol; 2015 Dec; 80(6):436-43. PubMed ID: 26741158
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HPV self-sampling among cervical cancer screening users in Spain: A randomized clinical trial of on-site training to increase the acceptability.
    Ibáñez R; Roura E; Acera A; Andújar M; Pavón MÀ; Bruni L; de Sanjosé S
    Prev Med; 2023 Aug; 173():107571. PubMed ID: 37308042
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acceptability of self-collected versus provider-collected sampling for HPV DNA testing among women in rural El Salvador.
    Rosenbaum AJ; Gage JC; Alfaro KM; Ditzian LR; Maza M; Scarinci IC; Felix JC; Castle PE; Villalta S; Miranda E; Cremer ML
    Int J Gynaecol Obstet; 2014 Aug; 126(2):156-60. PubMed ID: 24880188
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.